1. The Experimental Study of rALR on Immunologic Response Induced by Exogenous Antigen in Rat 2. Analysis on Cause of Death in 115 Patients with Hepatic Failure Induced by Viral Hepatitis 3. The Primary Clinical Study of Peginterferon Alfa-2a in the Treatment the Patients with HBeAg-Positive Chronic Hepatitis B and with Drug Fast to Lamivudine
1. Association of Polymorphisms of TNF-α and VDR Genes and HBV Genotype with Outcomes of Hepatitis B Virus Infection in Han Population of North China 2. Genetic Polymorphisms of TNF-α, VDR and elf-2α Genes and Response to Interferon Therapy in Patients with Chronic Hepatitis B: A Pilot Sduty
Results Mean plasma MDA concentration was 0.822+0.533 nmol/L for the acute hepatitis A group (n=11), 1.836±0.515 nmol/L for the acute hepatitis B group (n=25), and 0.589±0.227nmol/L for the control group (n=27), respectively.
This study evaluates the survival outcomes of patients who underwent living-donor liver transplantation (LDLT) using right lobe liver grafts for fulminant liver failure due to hepatitis B infection.
Expression and Characterization of Hepatitis B Surface Antigen in Transgenic Potato Plants
Transgenic potato plants expressing the gene of hepatitis B surface antigen (HBsAg) under the control of the double promoter of 35S RNA of cauliflower mosaic virus (CaMV 35SS) and the promoter of patatin gene of potato tubers have been obtained.
The molecular weight of HBsAg peptide was approximately 24 kD, which is in agreement with the size of the major protein of the envelope of hepatitis B virus.
Therefore, as well as in recombinant HBsAg-yeast cells, assembling of HBsAg monomers into immunogenic aggregates takes place in HBsAg-transgenic potato, which can be used as a source of recombinant vaccine against hepatitis B virus.